Virtuoso robot wins FDA nod for bladder tumor removal

Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.

Conventional bladder tumor resection typically removes tumors in fragments, disrupting the tumor tissue, the Nashville, Tennessee-based surgical robotics company said. The en bloc resection technique enabled by Virtuoso’s technology can remove tumors in one piece or larger segments.

“Removing a tumor intact can provide a better tissue specimen, which supports clearer diagnosis and staging,” Dr. Duke Herrell, urologic surgeon and Virtuoso’s CEO, said in a statement.

The approach is designed to preserve the tissue and information pathologists need to plan treatment.

Sign up for Blog Updates